Embedded Files
Session 26
08:30 - 09:00
Updates in the treatment of Chagas Disease: An evidence-based perspective in a clinical context.
Speaker:
Dr. Arianne Hernández. Hospital Clínico, Universidad de Chile.
Session 27
09:00 - 09:30
Meiosis in Trypanosoma cruzi: a new hypothesis
Speaker:
Dr. Carlos Renato Machado
Universidade Federal de Minas Gerais
Session 28
09:30 - 10:00
New compounds for Chagas Disease treatment
Speaker:
Dr. Mauricio Moncada-Basoalto
Universidad Tecnológica Metropolitana, Chile
Session 29
10:00 - 10:30
Break
Session 30
10:30 - 11:00
Decoding the human immunopeptidome in T. cruzi infection
Speaker:
Dr. Karina Gómez
INGEBI
Session 31
11:00 - 11:30
Uncovering novel components of an interactome supporting mRNA export in trypanosomes
Speaker:
Dra. Andrea Avila
Session 32
11:30 - 12:00
The dynamics of Trypanosoma cruzi infection in wild caught Mepraia spinolai collected in summer and winter of an austral endemic area
Speaker:
Dr. Aldo Solari
Universidad de Chile
Session 33
12:00 - 14:00
Lunch and poster presentation
Session 34
14:30 - 14:30
Factors involved in Trypanosoma cruzi pathogenesis
Speaker:
Dr. Sergio Schenkmann
Universidad Federal de Sao Paulo, Brasil.
Session 35
14:30 - 15:00
Extracellular vesicles released by Trypanosoma cruzi as primary mediators of modulation of the host immune system
Speaker:
Speaker:
Dra. Ana Claudia Torrecilhas
Universidad Federal de Sao Paulo, Brasil.
Session 36
15:00 - 15:30
The genome of Trypanosoma cruzi: two decades after TriTryps
Speaker: Dr. Carlos Robello
Institut Pasteur Montevideo
Session 37
15:30 - 16:00
Unveiling the Hidden Diversity of T. cruzi Amastigotes
Speaker:
Dr. Guillermo Alonso
INGEBI
Session 38
16:00 - 16:30
Speaker:
Session 39
16:30 - 17:00
Design of MiniProteins that disrupt the TcCRKT nuclear complex
Speaker:
Esteban Serra
Universidad de Rosario
Session 40
17:00 - 17:30
Speaker:
Session 41
17:30
Speaker:
Page updated
Google Sites
Report abuse